Home › Compare › SRAX vs EQR

SRAX vs EQR: Dividend Comparison 2026

SRAX yields 200000.00% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRAX wins by $4.911780474428384e+29M in total portfolio value
10 years
SRAX
SRAX
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full SRAX calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SRAX vs EQR

📍 SRAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRAXEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRAX + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SRAX pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRAX
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SRAX beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRAX + EQR for your $10,000?

SRAX: 50%EQR: 50%
100% EQR50/50100% SRAX
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SRAX
Analyst Ratings
5
Buy
Consensus: Buy
Price Target
$6.00
+599900.0% upside vs current
Range: $6.00 — $6.00
Altman Z
-9.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRAX buys
0
EQR buys
0
No recent congressional trades found for SRAX or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRAXEQR
Forward yield200000.00% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$4.911780474428384e+29M$47.8K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$4.911464459982279e+29M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$6.00$70.35 ✓

Year-by-year: SRAX vs EQR ($10,000, DRIP)

YearSRAX PortfolioSRAX Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,380$679.82+$20.00M → SRAX
2$37,424,589,019$37,403,177,570.09$13,014$837.25+$37424.58M → SRAX
3$65,416,215,188,220$65,376,170,877,969.18$14,961$1,036.20+$65416215.17M → SRAX
4$106,868,230,495,008,900$106,798,235,144,757,520.00$17,297$1,289.22+$106868230494.99M → SRAX
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$20,121$1,613.15+$163172871735896.84M → SRAX
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$23,561$2,030.84+$232854599801468864.00M → SRAX
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,783$2,573.54+$310570858137017057280.00M → SRAX
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$33,013$3,284.39+$3.871481543016132e+23M → SRAX
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$39,547$4,223.51+$4.510617497632811e+26M → SRAX
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$47,791$5,475.61+$4.911780474428384e+29M → SRAX

SRAX vs EQR: Complete Analysis 2026

SRAX — Stock

SRAX, Inc., a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc. in August 2019. SRAX, Inc. was founded in 2009 and is headquartered in Westlake Village, California.

Full SRAX Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SRAX vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRAX vs SCHDSRAX vs JEPISRAX vs OSRAX vs KOSRAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.